Overview Fundamentals API Earnings EOD API Sample Code Pricing

Neximmune Inc (NEXI NASDAQ) stock market data APIs

$2.5 -0.48(-16.1%) as of July 12, 2024
Price chart is built with Anychart

NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases in the United States. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's product candidates include NEXI-001, an allogeneic cell therapy, which is in Phase I/II clinical trials for the treatment of patients with acute myeloid leukemia; NEXI-002, an autologous cell therapy that is in Phase I/II clinical trials for the treatment of patients with relapsed and/or refractory in multiple myeloma; and NEXI-003, a product candidate targeted against HPV related cancers, which is in Phase I/II clinical trials. It provides NEXI-004 which is in preclinical stage for EBV related diseases; and NEXI005 designs for patient with specific targets for solid tumors. NexImmune, Inc. was incorporated in 2011 and is headquartered in Gaithersburg, Maryland.

Neximmune Inc Financial Data Overview

2.98
2.5
-
3.23
2.25
1.25-21
5 388 K
1 371 K
0
-2.4608
1.937
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'NEXI',
Type: 'Common Stock',
Name: 'Neximmune Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG007SK6360',
ISIN: NULL,
CUSIP: NULL,
CIK: '1538210',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2021-02-12',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,
}

Neximmune Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA -21 238 792
  • Earnings Per Share -24.11
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Neximmune Inc Earnings via APIs

  • Latest Release 2024-04-16
  • EPS/Forecast NaN

Get Neximmune Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com